Carter Bankshares Authorizes $10 Million Share Repurchase Program
CARE sits 57% above its 52-week low of $13.605 on elevated volume (2.2× avg).
Summary
Carter Bankshares announced a new $10 million common share repurchase program, signaling management confidence and potentially boosting shareholder value.
Key Events · Financing and Capital Events · CARE
-
Share Repurchase Program Authorized
The Board of Directors approved a common share repurchase program to buy back up to $10,000,000 of the company's common stock.
-
Program Details and Conditions
The program will run for twelve months from the date of non-objection from the Federal Reserve Bank of Richmond and allows for purchases in open market or privately negotiated transactions. The actual timing and amount are at management's discretion.
-
Follows Strong Earnings Report
This authorization comes shortly after the company reported strong financial results for the fourth quarter and full year 2025 on January 29, 2026.
Analysis · CARE · Finance
Carter Bankshares' Board of Directors has authorized a new share repurchase program for up to $10 million, representing a notable portion of the company's market capitalization. This move signals management's confidence in the company's valuation and financial health, especially following the strong fourth quarter and full year 2025 financial results reported just days prior. Share repurchases can enhance shareholder value by reducing the number of outstanding shares, thereby increasing earnings per share. The program is subject to regulatory non-objection from the Federal Reserve Bank of Richmond, which is a standard requirement for financial institutions.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 36.7% of the 1072 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.61%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CARE was trading at $21.41 on NASDAQ in the Finance sector, with a market capitalization of approximately $472.9M. The 52-week trading range was $13.61 to $21.57. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.